Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa te (non-preferred name)(CAS: 95716-98-6)
![Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa
te (non-preferred name) Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa
te (non-preferred name)](https://static.chemtradehub.com/structs/957/95716-98-6-9317.webp)
CAS Number
Related Products
Tetrachloro-BPF
CAS Number: 3933-88-8
3-(2-Oxo-2-phenylethyl)benzamide
CAS Number: 465514-78-7
2-ethynylaniline
CAS Number: 52670-38-9
4-Benzoyl-1-indanecarboxylic acid
CAS Number: 56461-33-7
Ethyl sulfurochloridate
CAS Number: 625-01-4
Articaine-014
CAS Number: 23964-64-9
15(R)-19(R)-Hydroxy prostaglandin E2
CAS Number: 54142-29-9
Other Suppliers for Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa te (non-preferred name)
Basic Information
Molecular Formula
C24H31KO7
Molecular Weight
470.6 g/mol
Chemical Identifiers
SMILES
CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC5(CCC(=O)[O-])O)C)C(=O)OC.[K+]
InChIKey
PRKXKJMKEHYPBV-PUDZRVQSSA-M
Database References
MDL Number
MFCD11982550
FAQ
The compound is subject to various regulatory guidelines including GHS classification, which may categorize it under specific hazard classes. REACH regulations require detailed safety data sheets and registration for substances above 1 tonne annually. The FDA and EPA may also have specific requirements related to its import, use, and disposal.
Alternative reagents, such as similar functionalized cyclopentaphenanthrene derivatives or simpler alkoxycarbonyl compounds, could be used as alternatives. However, the choice of alternative primarily depends on the specific reaction conditions and the desired end-product properties.
There is ongoing research into new applications for this compound, particularly in pharmaceuticals and materials science. Market trends suggest increased interest in novel chemical entities for therapeutic and industrial uses, alongside cost reductions and efficiency improvements in synthesis and purification processes.
Waste containing this compound should be collected in a sealed container and disposed of according to local regulations. Incineration or professional waste disposal services are recommended. Ensure proper environmental protection measures are in place, including the use of appropriate protective equipment and facilities to prevent contamination of the environment.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Xiao Zhang
2012558459@qq.com






![N-(4-{[(2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[3,2-d]pyrimidin-6-yl)methyl]amino}benzoyl)-L-glutamic acid](https://static.chemtradehub.com/structs/519/51989-29-8-63d5.webp)



![Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa
te (non-preferred name) — ShenZhenAiTaHuaXue Co Ltd](https://static.chemtradehub.com/suppliers/67ced0fb2b2de6e8e95a67fa/67ced0fb2b2de6e8e95a67fa-logo.webp)
![Potassium 3-[(4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-7-hydroxy-10-(methoxycarbonyl)-4a,6a-dimethyl-2-oxo-2,3,4,4a,5a,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[4b,5-b]oxiren-7-yl]propanoa
te (non-preferred name) — Shanghai Yuyeh Biotechnology Co., Ltd.](https://static.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)